Extremely obese people are needing a far higher dose of radiation during x-ray examinations than people of normal weight, increasing their risk of cancer, new research has shown.
All news from Radiology/ Radiotherapy
Panshak Dakup, a WSU Spokane graduate student, received a Pre?doctoral Fellowship from the American Heart Association. The two?year fellowship comes with $53,688 to support his research, which he is conducting in the laboratory of Shobhan Gaddameedhi at the WSU College of Pharmacy and Pharmaceutical Sciences (CPPS).
Radiotherapy for the treatment of "minimal" positive axillary lymph nodes in patients with early-stage breast cancer was comparable in efficacy and was associated with a significantly lower rate of the feared side effect of lymphedema compared to surgery, new 10-year data from a major randomized trial indicate.
Proton beam therapy, which has struggled to live up to its promise for treating cancer, is poised for a resurgence in St. Louis. As several other proton centers across the country shut down or file for bankruptcy, Siteman Cancer Center has doubled down on the technology. Its second machine is set to open in 2020.
Hitachi, Ltd. announced today that its heavy ion beam therapy system has started treatment at Osaka Heavy Ion Therapy Center as of October 16. This marks the first operation of Hitachi’s first heavy ion therapy system.
Data from the NRG (NSABP B-39/RTOG 0413) trial indicated that ipsilateral breast tumor recurrence (IBTR) rates 10 years after treatment could not reject the hypothesis that accelerated partial breast irradiation (PBI) after lumpectomy was inferior to whole breast irradiation (WBI), according to a presentation at the 2018 San Antonio Breast Cancer Symposium, held Dec.
The liver is the primary site of metastases in colorectal cancer (CRC) because most the venous mesenteric drainage enters the hepatic portal venous circulation. More than 50% of patients with CRC will develop hepatic metastases over the course of their life. This ultimately leads to death more than two-thirds of these patients.
Stereotactic body radiation therapy with CyberKnife for prostate cancer has long treatment times compared with conventional radiotherapy. This arises the need for designing treatment plans with short execution times.
Only few ten radiotherapy facilities worldwide provide ion beams, in spite of their physical advantage of better achievable tumor conformity of the dose compared to conventional photon beams. Since mainly the large size and high costs hinder their wider spread, great efforts are ongoing to develop more compact ion therapy facilities.
Radiation oncologists at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) are now treating patients with the GammaPod™, a new FDA-cleared radiation therapy for early-stage breast cancer.
Radiation-induced bystander effect (RIBE) is a poorly understood phenomenon wherein non-targeted cells exhibit effects of radiation. The researchers have reported that cell-free chromatin (cfCh) particles that are released from dying cells can integrate into genomes of surrounding healthy cells to induce DNA damage and inflammation.